Journal article
Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes
Abstract
INTRODUCTION: Peritoneal mesothelioma (PM) is a rare malignancy originating from the peritoneal lining. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is the standard-of-care for patients with isolated PM. Due to a paucity of prospective data there are several different HIPEC protocols. The aims of this study are to describe the CRS and HIPEC protocols for PM and patient outcomes across Canada.
METHODS: A …
Authors
Deban M; Taqi K; Knapp GC; Soucisse M; Curry M; Sidéris L; Dubé P; Al Khaldi M; Jedrzejko N; Porter G
Journal
Journal of Surgical Oncology, Vol. 128, No. 4, pp. 595–603
Publisher
Wiley
Publication Date
September 2023
DOI
10.1002/jso.27301
ISSN
0022-4790
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
HumansMaleMiddle AgedFemaleRetrospective StudiesProspective StudiesCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyPercutaneous Coronary InterventionHyperthermia, InducedCanadaMesothelioma, MalignantMesotheliomaPeritoneal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapySurvival Rate